Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Infectious surgical site complications after oral antibiotic bowel preparation for minimally-invasive rectal cancer surgery

ABSTRACT: Interventions: Drug : 1. experimental group (A) - mechanical bowel preparation (PEG) + IV antibiotics 2. control group (B) - mechanical bowel preparation (PEG) + IV antibiotics + oral antibiotics (rifaximin + metronidazole) 3. pre-operative preparation 3.1. mechanical bowel preparation - PEG prefered - water only permitted on the day before operation 3.2. oral antibiotics - 14, 16, 22 hour the day before surgery - 400mg rifaximin + 500mg metronidazole 3.3. IV antibiotics - 2nd generation cephalosporin - venous injection within 30 minutes before surgery - additional dose is at the discretion of the operators Primary outcome(s): surgical site infection rate during first 30 days Primary Purpose : Prevention, Intervention Model : Factorial, Blinding/Masking : Open, Allocation : RCT

DISEASE(S): Neoplasms

PROVIDER: 2512754 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Mechanical Bowel Preparation and Oral Antibiotics Before Colon Cancer Surgery

Project description:This study aims to demonstrate that a preoperative combination of mechanical bowel preparation and oral antibiotics, before elective laparoscopic colon cancer surgery, is associated with a reduction of postoperative surgical site infection rate, as compared to mechanical bowel preparation alone, oral antibiotics alone, or no colonic preparation. Our Hypothesis is that a preoperative colonic preparation including a combination of mechanical bowel preparation and oral antibiotics before elective laparoscopic colon cancer surgery is associated with a reduced rate of 30-day postoperative surgical site infection, as compared to mechanical bowel preparation alone, oral antibiotics alone, or no colonic preparation.

| 2269131 | ecrin-mdr-crc

Mechanical Bowel Preparation and Oral Antibiotics Before Rectal Cancer Surgery

Project description:This study aims to demonstrate that a preoperative combination of mechanical bowel preparation and oral antibiotics, before elective laparoscopic rectal cancer surgery, is associated with a reduction of postoperative surgical site infection rate, as compared to mechanical bowel preparation alone Our hypothesis is that a preoperative colonic preparation including a combination of mechanical bowel preparation and oral antibiotics before elective laparoscopic rectal cancer surgery is associated with a reduced rate of 30-day postoperative surgical site infection, as compared to mechanical bowel preparation alone

| 2270348 | ecrin-mdr-crc

Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer Surgery

Project description:Investigation of the role of adding oral antibiotics to preoperative mechanical bowel preparation before colorectal surgery for cancer.

| 2275878 | ecrin-mdr-crc

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone

Project description:The purpose of the study is to determine if short-term outcomes of rectal resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to rectal resections with only mechanical bowel preparation.

| 2354896 | ecrin-mdr-crc

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation

Project description:The purpose of the study is to determine if short-term outcomes of colon resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to colon resections with no bowel preparation.

| 2748859 | ecrin-mdr-crc

Preoperative less painful mechanical bowel preparation in elective resection colorectal cancer surgery: a multicenter randomized non-Inferiority study

Project description:Interventions: mOAMBP group(sodium picosulfate hydrate + Kanamycin, Metronidazole) (combined drug) Kanamycin 250mg 12C x3(after lunch, dinner, and before bedtime) and Metronidazole 250mg 6C x3(after lunch, dinner, and before bedtime) per oral the day before surgery (research drug) (1 day method) sodium picosulfate hydrate 75.0mg(after hospitalization) per oral or (2 days method) sodium picosulfate hydrate 37.5 mg two days before surgery(after hospitalization) and 37.5 mg the day before surgery(morning) per oral OAMBP group(PEG/PEG based solution + Kanamycin, Metronidazole) (combined drug) Kanamycin 250mg 12C x3(after lunch, dinner, and before bedtime) and Metronidazole 250mg 6C x3(after lunch, dinner, and before bedtime) per oral the day before surgery (control drug) (1 day method) 1 pack of PEG/ PEG based solution the day before surgery(after hospitalization) per oral (2 days method) 1 pack of PEG/ PEG based solution two days before surgery(after hospitalization) per oral Primary outcome(s): Incidence of SSI Study Design: Parallel Randomized

| 2659463 | ecrin-mdr-crc

Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery

Project description:MOBILE2 is a randomized controlled trial comparing mechanical and oral antibiotic bowel preparation to mechanical bowel preparation only in patients undergoing anterior rectal resection with primary anastomosis. Primary endpoint is Comprehensive Complication Index within 30 days from surgery.

| 2331037 | ecrin-mdr-crc

Role of oral antibiotics in reducing the chance of infection after operations for cancer of the rectum

Project description:Intervention1: Oral antibiotic bowel preparation: All the patients in this arm in addition to the bowel preparation solution ( 45 ml of Exelyte bowel preparation solution ( monobasic sodium phosphate dihydrate 24.417 g, disodium hydrogen orthophosphate dihydrate 5.439 g) to be consumed at 8 am and 4 pm ), will also receive 3 tablets each of, 1 gm of Erythromycin Estolate and 400 mg of Metronidazole in the package, to be taken at 1pm, 2pm and 11 pm, on the day prior to surgery Control Intervention1: Mechanical Bowel preparation : Exelyte: 2 bottles of 45 ml of Exelyte bowel preparation solution ( monobasic sodium phosphate dihydrate 24.417 g, disodium hydrogen orthophosphate dihydrate 5.439 g) to be consumed at 8 am and 4 pm on the day prior to surgery. Primary outcome(s): . To evaluate and assess the superiority of oral antibiotic bowel preparation in reducing incidence of surgical site infections in patients undergoing elective resection for rectal cancer in comparison to only mechanical bowel preparation at a tertiary care center in India.Timepoint: 30 days from the day of surgery Study Design: Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Outcome Assessor Blinded

| 2585601 | ecrin-mdr-crc

Differences in vaginal microbiota, host transcriptome and proteins in women with bacterial vaginosis are associated with metronidazole treatment response

Project description:Bacterial vaginosis (BV) treatment failures or recurrences are common. To identify features associated with treatment response, we compared vaginal microbiota and host ectocervical transcriptome before and after oral metronidazole therapy. Response to metronidazole is characterized by significant changes in chemokines and related transcripts suggesting that strategies to promote these pathways may prove beneficial.

2021-05-21 | GSE174799 | GEO

A controlled study of efficacy and safety in CT colonography preparation with Mosapride Citrate Hydrate

Project description:Interventions: Polyethylene glycol lavage solution plus contrast medium (PEG-C) preparation before CT colonography Polyethylene glycol lavage solution plus contrast medium and Mosapride Citrate Hydrate (PEG-CM) preparation before CT colonography Primary outcome(s): PEG-C versus PEG-C + Mosapride Citrate Hydrate for bowel preparation before CT colonography to be asscessed by the amount of residual fluid. Study Design: Parallel Randomized

| 2620536 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data